Escitalopram oxalate -: Antidepressant -: 5-HT reuptake inhibitor

被引：8

作者：

Sorbera, LA ^{[1
]}

Revel, L ^{[1
]}

Martin, L ^{[1
]}

Castañer, J ^{[1
]}

机构：

[1] Prous Sci, Barcelona 08080, Spain

来源：

DRUGS OF THE FUTURE | 2001年 / 26卷 / 02期

关键词：

(+)-(S)-citalopram oxalate; Lu-26-054-0; Cipralex (TM);

D O I：

10.1358/dof.2001.026.02.610572

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：115 / 120

页数：6

共 50 条

[21] IFOXETINE - AN UNUSUAL 5-HT UPTAKE INHIBITOR OR AN INHIBITOR OF 5-HT RELEASE
WALDMEIER, PC
BAUMANN, PA
PHARMACOPSYCHIATRY, 1986, 19 (04) : 318 - 319
[22] S41744, a dual NK1 antagonist/5-HT reuptake inhibitor and antidepressant: a comparison to aprepitant and paroxetine
Brocco, M.
Gobert, A.
la Cour, C. Mannoury
Dekeyne, A.
De Nanteuil, G.
Olivier, B.
De Jong, T. R.
Cremers, T. I.
Flick, G.
Millan, M. J.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S432 - S432
[23] THERAPEUTIC WINDOW FOR 5-HT REUPTAKE INHIBITORS
PITCHOT, W
GONZALEZMORENO, A
ANSSEAU, M
LANCET, 1992, 339 (8794): : 689 - 689
[24] Combined administration of a 5-hydroxytryptamine (5-HT)(1D) antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo
Rollema, H
Clarke, T
Sprouse, JS
Schulz, DW
JOURNAL OF NEUROCHEMISTRY, 1996, 67 (05) : 2204 - 2207
[25] Clarifications on the effects of 5-HT1A agonists and selective 5-HT reuptake inhibitors on the 5-HT system
Blier, P
deMontigny, C
NEUROPSYCHOPHARMACOLOGY, 1996, 15 (02) : 213 - 214
[26] DO REUPTAKE INHIBITORS INCREASE EXTRACELLULAR 5-HT IN ALL TERMINAL REGIONS - MICRODIALYSIS STUDIES WITH 5-HT REUPTAKE INHIBITORS
FULLER, RW
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (11) : 397 - 397
[27] Selective 5-HT or NA reuptake inhibitors vs mixed 5-HT/NA reuptake inhibitors in animal models of pain
Sanchez, C
BIOLOGICAL PSYCHIATRY, 2004, 55 : 112S - 112S
[28] A 55 MIN TIME TRIAL PERFORMANCE IS NOT INFLUENCED BY A 5-HT/NA REUPTAKE INHIBITOR
Piacentini, M. F.
Buyse, L.
De Schutter, G.
Meeusen, R.
DeMeirleir, K.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2001, 33 (05): : S288 - S288
[29] Role of CCK in anti-exploratory action of paroxetine, 5-HT reuptake inhibitor
Koks, S
Bourin, M
Voikar, V
Soosaar, A
Vasar, E
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 1999, 2 (01): : 9 - 16
[30] Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo
Sharp, T
Umbers, V
Gartside, SE
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (05) : 941 - 946

← 1 2 3 4 5 →